[{"abstract": "The American pharmaceutical giant is trying to convince British lawmakers that a Pfizer-AstraZeneca combination is viable.", "web_url": "https://dealbook.nytimes.com/2014/05/12/pfizer-and-astrazeneca-step-up-war-of-words-over-potential-merger/", "snippet": "The American pharmaceutical giant is trying to convince British lawmakers that a Pfizer-AstraZeneca combination is viable.", "lead_paragraph": "Updated, 7:37 p.m. | LONDON \u2013 Pfizer pledged on Monday to keep jobs in Britain if it succeeds in taking over the British drug maker AstraZeneca, and it questioned whether AstraZeneca can stand on its own much longer.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/13/business/dbpix-drug2/dbpix-drug2-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/05/13/business/dbpix-drug2/dbpix-drug2-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/13/business/dbpix-drug2/dbpix-drug2-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/13/business/dbpix-drug2/dbpix-drug2-superJumbo.jpg", "height": 1365, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/13/business/dbpix-drug2/dbpix-drug2-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/05/13/business/dbpix-drug2/dbpix-drug2-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/05/13/business/dbpix-drug2/dbpix-drug2-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Pursuing AstraZeneca, Pfizer Pledges to Keep Jobs in Britain", "kicker": "DealBook", "content_kicker": null, "print_headline": "Pursuing AstraZeneca, Pfizer Pledges to Keep Jobs in Britain", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "persons", "value": "Read, Ian C", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 5, "major": "N"}], "pub_date": "2014-05-12T11:06:55+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Chad Bray", "person": [{"firstname": "Chad", "middlename": null, "lastname": "Bray", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/a7094a9f-f819-585c-8e7f-257246efe413", "word_count": 714, "uri": "nyt://article/a7094a9f-f819-585c-8e7f-257246efe413"}, {"abstract": "BNP Paribas and Credit Suisse ask authorities in the United States to go easy. | Pfizer goes online to defend its bid for AstraZeneca. | Timothy F. Geithner\u2019s book, \u201cStress Test,\u201d comes out today. | Morgan Stanley is king in Silicon Valley.", "web_url": "https://dealbook.nytimes.com/2014/05/12/morning-agenda-2-banking-giants-ask-for-leniency/", "snippet": "BNP Paribas and Credit Suisse ask authorities in the United States to go easy. | Pfizer goes online to defend its bid for AstraZeneca. | Timothy F. Geithner\u2019s book, \u201cStress Test,\u201d comes out today. | Morgan Stanley is king in Silicon Valley.", "lead_paragraph": "Facing the threat of criminal charges, BNP Paribas and Credit Suisse are imploring authorities in the United States for leniency, Ben Protess and Jessica Silver-Greenberg write in DealBook. To avoid fallout from pleading guilty, the banks are said to have made last-ditch appeals to prosecutors and regulators in recent weeks.", "source": "The New York Times", "multimedia": [], "headline": {"main": "BNP Paribas and Credit Suisse Seek Leniency", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2014-05-12T11:41:22+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Sydney Ember", "person": [{"firstname": "Sydney", "middlename": null, "lastname": "Ember", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/c8028602-229a-53ca-a22b-f5aa54ebb5b6", "word_count": 1839, "uri": "nyt://article/c8028602-229a-53ca-a22b-f5aa54ebb5b6"}]